Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shelya X Zeng

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Toxicology Reports|July 14, 2015
Determination of Maximum Tolerated Dose and Toxicity of Inauhzin in MiceQi Zhang, Shelya X Zeng, Hua Lu
The Journal of Biological Chemistry|June 29, 2006
UV Induces p21 rapid turnover independently of ubiquitin and Skp2Hunjoo Lee, Shelya X Zeng, Hua Lu
Sub-Cellular Biochemistry|September 10, 2014
Targeting p53-MDM2-MDMX loop for cancer therapyQi Zhang, Shelya X Zeng, Hua Lu
The Journal of Biological Chemistry|April 16, 2008
Phosphorylation and stabilization of TAp63gamma by IkappaB kinase-betaMary MacPartlin, Shelya X Zeng, Hua Lu
Methods in Molecular Biology (Clifton, N.J.)|June 26, 2003
Interaction of p53 with cellular proteinsDavid M Keller, Shelya X Zeng, Hua Lu
The Journal of Biological Chemistry|January 9, 2007
Human SSRP1 has Spt16-dependent and -independent roles in gene transcriptionYanping Li, Shelya X Zeng, Igor Landais, et al.
Developmental Biology|January 26, 2017
Monitoring p53 by MDM2 and MDMX is required for endocrine pancreas development and function in a spatio-temporal mannerYiwei Zhang, Shelya X Zeng, Qian Hao, et al.
Cancer Biology & Therapy|November 22, 2019
Co-targeting p53-R249S and CDK4 synergistically suppresses survival of hepatocellular carcinoma cellsHuai Wang, Peng Liao, Shelya X Zeng, et al.
The Journal of Biological Chemistry|February 11, 2004
MDM2 mediates p300/CREB-binding protein-associated factor ubiquitination and degradationYetao Jin, Shelya X Zeng, Hunjoo Lee, et al.
Pharmacology & Therapeutics|March 30, 2017
Reviving the guardian of the genome: Small molecule activators of p53Daniel Nguyen, Wenjuan Liao, Shelya X Zeng, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Toxicology Reports|July 14, 2015
Determination of Maximum Tolerated Dose and Toxicity of Inauhzin in MiceQi Zhang, Shelya X Zeng, Hua Lu
The Journal of Biological Chemistry|June 29, 2006
UV Induces p21 rapid turnover independently of ubiquitin and Skp2Hunjoo Lee, Shelya X Zeng, Hua Lu
Sub-Cellular Biochemistry|September 10, 2014
Targeting p53-MDM2-MDMX loop for cancer therapyQi Zhang, Shelya X Zeng, Hua Lu
The Journal of Biological Chemistry|April 16, 2008
Phosphorylation and stabilization of TAp63gamma by IkappaB kinase-betaMary MacPartlin, Shelya X Zeng, Hua Lu
Methods in Molecular Biology (Clifton, N.J.)|June 26, 2003
Interaction of p53 with cellular proteinsDavid M Keller, Shelya X Zeng, Hua Lu
The Journal of Biological Chemistry|January 9, 2007
Human SSRP1 has Spt16-dependent and -independent roles in gene transcriptionYanping Li, Shelya X Zeng, Igor Landais, et al.
Developmental Biology|January 26, 2017
Monitoring p53 by MDM2 and MDMX is required for endocrine pancreas development and function in a spatio-temporal mannerYiwei Zhang, Shelya X Zeng, Qian Hao, et al.
Cancer Biology & Therapy|November 22, 2019
Co-targeting p53-R249S and CDK4 synergistically suppresses survival of hepatocellular carcinoma cellsHuai Wang, Peng Liao, Shelya X Zeng, et al.
The Journal of Biological Chemistry|February 11, 2004
MDM2 mediates p300/CREB-binding protein-associated factor ubiquitination and degradationYetao Jin, Shelya X Zeng, Hunjoo Lee, et al.
Pharmacology & Therapeutics|March 30, 2017
Reviving the guardian of the genome: Small molecule activators of p53Daniel Nguyen, Wenjuan Liao, Shelya X Zeng, et al.
Pageof 6